M1 Kliniken AG header image

M1 Kliniken AG

M12

Equity

ISIN DE000A0STSQ8 / Valor 29694419

Xetra (2025-04-08)
EUR 13.90+0.72%

M1 Kliniken AG
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

M1 Kliniken AG is a German-based company specializing in the provision of health services and medical treatments, particularly in the field of aesthetic medicine.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.08.2024):

Revenue Growth

In the first quarter of 2024, M1 Kliniken AG reported a 9.6% increase in consolidated sales, rising from EUR 76.8 million to EUR 84.7 million. This growth was primarily driven by the company's core Beauty segment, which continues to expand its market position worldwide.

Operating Earnings

M1 Kliniken AG saw a significant increase in operating earnings before interest and taxes (EBIT) in Q1 2024. The Group's EBIT rose by 70%, from EUR 4.0 million to EUR 6.8 million, resulting in an EBIT margin increase from 5.3% to 8.1%.

Beauty Segment Performance

The Beauty segment of M1 Kliniken AG showed particularly strong performance in Q1 2024. Sales in this segment increased by 18.2%, from EUR 20.9 million to EUR 24.7 million, while EBIT surged by 50%, from EUR 3.6 million to EUR 5.4 million. The EBIT margin for this segment improved from 17.3% to 21.9%.

Trading Segment Results

In the trading segment, M1 Kliniken AG also reported positive results for Q1 2024. Sales increased from EUR 55.9 million to EUR 60.0 million, and segment EBIT improved from EUR 0.4 million to EUR 1.4 million, reflecting the company's strong operational performance.

Future Outlook

M1 Kliniken AG is optimistic about its future growth, focusing on expanding its "M1 Med Beauty" network. The company aims to operate 150 to 200 specialist medical centers for aesthetic medicine by the end of 2029, with projected revenue of EUR 200 to 300 million and an EBIT margin of at least 20%. Additionally, M1 is considering strategic options for its trading segment to enhance shareholder value.

Summarized from source with an LLMView Source

Key figures

-0.36%1Y
87.3%3Y
17.8%5Y

Performance

50.6%1Y
49.4%3Y
50.0%5Y

Volatility

Market cap

327 M

Market cap (USD)

Daily traded volume (Shares)

8,940

Daily traded volume (Shares)

1 day high/low

16.45 / 15.8

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Legend Biotech Corporation
Legend Biotech Corporation Legend Biotech Corporation Valor: 54834759
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.72%USD 30.77
Concentra Group Holdings Parent Inc
Concentra Group Holdings Parent Inc Concentra Group Holdings Parent Inc Valor: 136105334
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.93%USD 19.83
aap Implantate AG
aap Implantate AG aap Implantate AG Valor: 57872565
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.23%EUR 1.65
DENTSPLY SIRONA Inc
DENTSPLY SIRONA Inc DENTSPLY SIRONA Inc Valor: 31773200
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.38%USD 12.66
Acadia Healthcare Co Inc
Acadia Healthcare Co Inc Acadia Healthcare Co Inc Valor: 14151414
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.65%USD 27.12
Galapagos NV
Galapagos NV Galapagos NV Valor: 3542077
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.08%USD 23.52
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Bristol-Myers Squibb Co Valor: 914188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.84%USD 53.07
Encompass Health Corporation
Encompass Health Corporation Encompass Health Corporation Valor: 39085960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.24%USD 97.91
International Flavors & Fragrances Inc
International Flavors & Fragrances Inc International Flavors & Fragrances Inc Valor: 941876
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.46%USD 66.85
ACELYRIN INC
ACELYRIN INC ACELYRIN INC Valor: 126441937
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-9.96%USD 2.08